Shuttle Pharmaceuticals Holdings (SHPH) Times Interest Earned (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Times Interest Earned of -$7.39 for Q1 2026, up 49.92% year-over-year from -$4.93 in Q1 2025, and up 66.87% quarter-over-quarter from -$22.31 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Times Interest Earned (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$7.39 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 49.92% year-over-year to -$7.39; the TTM figure through Mar 2026 stood at -$15.42 (up 76.79% YoY), while the FY2025 annual figure was -$1.53, down 0.54% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$7.39, up from -$22.31 in the prior quarter.
- The five-year high for Times Interest Earned was $2.57 in Q4 2024, with the low at -$49.29 in Q3 2022.
- The 5-year median for Times Interest Earned is -$12.49 (2025), against an average of -$14.12.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned jumped 209.79% in 2024, then plunged 967.72% in 2025.
- Shuttle Pharmaceuticals Holdings' Times Interest Earned stood at -$24.43 in 2022, then surged by 90.41% to -$2.34 in 2023, then surged by 209.79% to $2.57 in 2024, then slumped by 967.72% to -$22.31 in 2025, then soared by 66.87% to -$7.39 in 2026.
- Business Quant data shows SHPH's Times Interest Earned at -$7.39 in Q1 2026, -$22.31 in Q4 2025, and -$22.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | -182.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.39 |
| Dec 31, 2025 | -22.31 |
| Sep 30, 2025 | -22.67 |
| Jun 30, 2025 | -12.49 |
| Mar 31, 2025 | -14.76 |
| Dec 31, 2024 | 2.57 |
| Sep 30, 2024 | -15.26 |
| Jun 30, 2024 | -3.44 |
| Mar 31, 2024 | -2.78 |
| Dec 31, 2023 | -2.34 |
| Sep 30, 2023 | -2.56 |
| Jun 30, 2023 | -2.67 |
| Mar 31, 2023 | -2.58 |
| Dec 31, 2022 | -24.43 |
| Sep 30, 2022 | -49.29 |
| Jun 30, 2022 | -23.84 |
| Mar 31, 2022 | -33.83 |
| Sep 30, 2021 | -22.96 |